| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5562190 | Toxicology Letters | 2017 | 29 Pages |
Abstract
α-LA treatment ameliorated cisplatin-induced AKI. Protection was demonstrated by reduced structural damage, improved glomerular filtration and reduced excretion of urinary biomarkers of proximal tubular damage. Effective treatment of AKI can be monitored by site and perhaps by mechanism-specific kidney damage biomarkers.
Related Topics
Life Sciences
Environmental Science
Health, Toxicology and Mutagenesis
Authors
T.J. Pianta, L. Succar, T. Davidson, N.A. Buckley, Z.H. Endre,